Your Client Rank:
Loading...
99
Updated 28-Jan-2021
| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Astra | 11.1% | 0.2% | -5.3% | -3.7% | 9.2% | -0.3% | 19.1% | 19.1% |
| Daiichi | 10.8% | 2.8% | -1.2% | -8.4% | 31.5% | 1.9% | 41.8% | 42.0% |
| Vertex | 10.1% | 0.1% | -0.7% | -4.3% | 2.5% | 14.9% | 12.2% | 11.2% |
| Viatris | 8.5% | 2.6% | -0.9% | -0.6% | 6.2% | -1.8% | 17.6% | 0.1% |
| Lilly | 7.7% | 0.4% | -4.0% | -3.1% | 5.2% | 1.4% | 11.6% | 12.2% |
| Eisai | 7.5% | 1.1% | -0.5% | -6.5% | 14.0% | 1.5% | 21.8% | 21.9% |
| Novo | 6.8% | -0.1% | -0.9% | 0.9% | 0.2% | -0.1% | 7.4% | 9.0% |
| Alexion | 6.5% | -0.1% | 0.0% | 2.1% | -0.9% | 0.6% | 5.8% | 7.2% |
| Regeneron | 6.3% | -0.3% | 0.0% | -2.7% | -0.3% | 4.7% | 7.1% | 6.5% |
| Chugai | 5.3% | 1.4% | -1.8% | 0.4% | 2.2% | -0.4% | 7.7% | 7.8% |
| Shionogi | 4.9% | -0.3% | -2.0% | -3.3% | -0.9% | 0.0% | 3.5% | 4.2% |
| Merck | 4.6% | 0.7% | -1.8% | -2.0% | 3.3% | 2.2% | 6.8% | 8.0% |
| Roche | 4.5% | 0.3% | -1.3% | -1.0% | 1.7% | 0.8% | 6.7% | 6.8% |
| Glaxo | 4.2% | 0.2% | -1.3% | 1.4% | 1.6% | 3.1% | 5.4% | 5.2% |
| JnJ | 4.1% | 0.5% | -1.1% | -1.5% | 2.4% | 2.1% | 6.3% | 7.1% |
| AbbVie | 3.9% | -0.6% | -1.3% | -1.0% | 0.1% | 3.5% | 4.3% | 3.9% |
| Astellas | 3.7% | -0.1% | 0.1% | -1.9% | 0.8% | 2.8% | 4.3% | 10.6% |
| Sanofi | 3.7% | 0.6% | -3.5% | -2.8% | 5.4% | -0.4% | 7.5% | 7.6% |
| Novartis | 3.4% | 0.1% | -0.8% | -0.4% | 1.6% | 1.0% | 5.8% | 6.5% |
| Bristol | 3.3% | -0.6% | -2.8% | -1.3% | 0.9% | 0.2% | 5.2% | 5.7% |
| Lundbeck | 2.9% | 1.1% | -1.4% | -4.1% | 19.4% | -2.4% | 7.7% | 7.7% |
| Amgen | 2.7% | -0.2% | -0.8% | 0.0% | -0.2% | 0.9% | 3.7% | 5.3% |
| Pfizer | 1.7% | 0.3% | -1.7% | -0.4% | 2.0% | 0.8% | 3.9% | 4.6% |
| Takeda | 1.3% | 1.1% | -2.1% | -2.0% | 8.7% | -14.3% | 27.3% | 27.2% |
| Gilead | 1.0% | 0.0% | -0.5% | -0.8% | 0.1% | 0.2% | 2.5% | 3.4% |
| Teva | 0.9% | 0.8% | -0.7% | -0.1% | 2.2% | 0.8% | 5.0% | 4.8% |
| Bayer | 0.6% | 3.2% | -2.8% | -6.5% | | 17.1% | 1.7% | 1.8% |
| Biogen | -2.8% | -0.4% | 3.5% | 2.5% | -2.3% | 0.2% | -5.9% | -3.1% |
| EU Major | 4.4% | 0.8% | -2.3% | -1.6% | 5.3% | -2.1% | 7.3% | 7.5% |
| Other EU | 2.9% | 1.1% | -1.4% | -4.1% | 19.4% | -2.4% | 7.7% | 7.7% |
| US Major | 4.0% | 0.1% | -1.8% | -1.4% | 2.0% | 1.8% | 5.9% | 7.1% |
| US Big Biotech | 2.8% | -0.1% | -0.2% | -0.2% | -0.3% | 1.3% | 3.5% | 4.2% |
| Other US | 4.3% | 1.8% | -0.8% | -0.8% | 4.7% | -0.6% | 11.7% | 1.8% |
| Japanese | 4.4% | 1.1% | -0.9% | -3.2% | 7.7% | -4.6% | 16.5% | 15.0% |
